Listed

China Pharma Holdings, Inc.: Form 10-Q for the period ended Sep 30, 2021

Filed with the SEC on Nov 12, 2021 and accepted by EDGAR at Nov 12, 2021, 16:06 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-07-01 to 2021-09-30$2.0mus-gaap:Revenues
Revenue9 months2021-01-01 to 2021-09-30$6.8mus-gaap:Revenues
Cost of revenue3 months2021-07-01 to 2021-09-30$2.3mus-gaap:CostOfRevenue
Cost of revenue9 months2021-01-01 to 2021-09-30$6.7mus-gaap:CostOfRevenue
Gross profit3 months2021-07-01 to 2021-09-30−$296.4kus-gaap:GrossProfit
Gross profit9 months2021-01-01 to 2021-09-30$47.3kus-gaap:GrossProfit
Research and development3 months2021-07-01 to 2021-09-30$21.4kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2021-01-01 to 2021-09-30$264.9kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-07-01 to 2021-09-30−$762.4kus-gaap:OperatingIncomeLoss
Operating income9 months2021-01-01 to 2021-09-30−$2.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-07-01 to 2021-09-30$64.9kus-gaap:InterestExpense
Interest expense9 months2021-01-01 to 2021-09-30$208.6kus-gaap:InterestExpense
Net income3 months2021-07-01 to 2021-09-30−$826.7kus-gaap:NetIncomeLoss
Net income9 months2021-01-01 to 2021-09-30−$2.4mus-gaap:NetIncomeLoss
Operating cash flow9 months2021-01-01 to 2021-09-30−$51.7kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2021-01-01 to 2021-09-30$431.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-09-30$458.8kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-09-30$4.1mus-gaap:AssetsCurrent
Total assetsAt period end2021-09-30$18.2mus-gaap:Assets
Current liabilitiesAt period end2021-09-30$10.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-09-30$11.3mus-gaap:Liabilities
Long-term debtAt period end2021-09-30$4.3mus-gaap:LongTermDebt
Shareholders' equityAt period end2021-09-30$6.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-21-058670. Last ingested by Listed: Nov 11, 2026, 00:23 ET. Listed shows no prices and gives no investment advice.